News

A blanket requirement for placebo-controlled trials threatens research ethics and vaccine access, it’s being argued.
Yes, according to leading vaccine physician Paul Offit, who denounced the new placebo-controlled trial requirements for ...
FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and ...
Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter ...